- Home
- GTIM vs RNXT Comparison
GTIM vs RNXT Comparison
Compare GTIM & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTIM
- RNXT
- Stock Information
- Founded
- GTIM 1987
- RNXT 2012
- Country
- GTIM United States
- RNXT United States
- Employees
- GTIM N/A
- RNXT N/A
- Industry
- GTIM Restaurants
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- GTIM Consumer Discretionary
- RNXT Health Care
- Exchange
- GTIM Nasdaq
- RNXT Nasdaq
- Market Cap
- GTIM 28.9M
- RNXT 30.0M
- IPO Year
- GTIM 1990
- RNXT 2021
- Fundamental
- Price
- GTIM $2.51
- RNXT $1.25
- Analyst Decision
- GTIM
- RNXT Strong Buy
- Analyst Count
- GTIM 0
- RNXT 2
- Target Price
- GTIM N/A
- RNXT $6.50
- AVG Volume (30 Days)
- GTIM 15.7K
- RNXT 112.3K
- Earning Date
- GTIM 12-12-2024
- RNXT 11-13-2024
- Dividend Yield
- GTIM N/A
- RNXT N/A
- EPS Growth
- GTIM N/A
- RNXT N/A
- EPS
- GTIM 0.14
- RNXT N/A
- Revenue
- GTIM $142,315,000.00
- RNXT N/A
- Revenue This Year
- GTIM N/A
- RNXT N/A
- Revenue Next Year
- GTIM N/A
- RNXT N/A
- P/E Ratio
- GTIM $17.93
- RNXT N/A
- Revenue Growth
- GTIM 3.01
- RNXT N/A
- 52 Week Low
- GTIM $2.18
- RNXT $0.77
- 52 Week High
- GTIM $3.45
- RNXT $2.35
- Technical
- Relative Strength Index (RSI)
- GTIM 37.61
- RNXT 51.48
- Support Level
- GTIM $2.50
- RNXT $1.10
- Resistance Level
- GTIM $2.59
- RNXT $1.31
- Average True Range (ATR)
- GTIM 0.12
- RNXT 0.14
- MACD
- GTIM -0.02
- RNXT -0.03
- Stochastic Oscillator
- GTIM 22.02
- RNXT 33.33
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; kids; breakfast; frozen custard; slides and drinks.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.